Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases
Abstract Background Hyperferritinemic syndromes are systemic inflammatory disorders characterized by a dysfunctional immune response, which leads to excessive activation of the monocyte-macrophage system with hypercytokinemia and may pursue a rapidly fatal course. Case presentation We describe two p...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Book |
Published: |
BMC,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!